Skip to main content

IRulya Therapeutics Inc.

IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662774

No open-market purchases or sales by IRulya Therapeutics Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q3 2026, worth $66.8M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in IRulya Therapeutics Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
+6 vs. Q2 2026
Shares held
2.22M
+1.89M (+573.7%) vs. Q2 2026
Total value
$66.8M
+$62.0M (+1,308.2%) vs. Q2 2026
New holders
10
14 more added
Sold out
4
4 more reduced

1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IRLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 32 institutions
Q1 2021: 91 institutionsQ2 2021: 105 institutionsQ3 2021: 131 institutionsQ4 2021: 102 institutionsQ1 2022: 88 institutionsQ2 2022: 70 institutionsQ3 2022: 61 institutionsQ4 2022: 50 institutionsQ1 2023: 45 institutionsQ2 2023: 40 institutionsQ3 2023: 42 institutionsQ4 2023: 44 institutionsQ1 2024: 46 institutionsQ2 2024: 43 institutionsQ3 2024: 34 institutionsQ4 2024: 36 institutionsQ1 2025: 37 institutionsQ2 2025: 41 institutionsQ3 2025: 46 institutionsQ4 2025: 69 institutionsQ1 2026: 48 institutionsQ2 2026: 27 institutionsQ3 2026: 32 institutions
Value heldQ3 2026: $66.8M
Q1 2021: $673.5MQ2 2021: $982.9MQ3 2021: $1.76BQ4 2021: $242.8MQ1 2022: $99.5MQ2 2022: $26.0MQ3 2022: $12.4MQ4 2022: $3.44MQ1 2023: $12.0MQ2 2023: $13.5MQ3 2023: $8.40MQ4 2023: $7.83MQ1 2024: $7.71MQ2 2024: $4.68MQ3 2024: $4.04MQ4 2024: $9.56MQ1 2025: $6.96MQ2 2025: $12.5MQ3 2025: $19.2MQ4 2025: $67.8MQ1 2026: $1.45MQ2 2026: $4.74MQ3 2026: $66.8M
Institutions holding IRLA and their total value by quarter
QuarterHoldersValue
Q3 202632$66.8M
Q2 202627$4.74M
Q1 202648$1.45M
Q4 202569$67.8M
Q3 202546$19.2M
Q2 202541$12.5M
Q1 202537$6.96M
Q4 202436$9.56M
Q3 202434$4.04M
Q2 202443$4.68M
Q1 202446$7.71M
Q4 202344$7.83M
Q3 202342$8.40M
Q2 202340$13.5M
Q1 202345$12.0M
Q4 202250$3.44M
Q3 202261$12.4M
Q2 202270$26.0M
Q1 202288$99.5M
Q4 2021102$242.8M
Q3 2021131$1.76B
Q2 2021105$982.9M
Q1 202191$673.5M

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding IRulya Therapeutics Inc.; share changes are against Q2 2026.

Institutions holding IRLA in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Janus Henderson Group PLC1,714,957$53.2M0.02%+1,714,957New
Ikarian Capital, LLC95,652$2.97M0.59%+23,401+32.4%Added
Squadron Capital Management LLC90,000$2.79M0.83%+49,625+122.9%Added
Millennium Management LLC72,254$2.24M0.00%+1,475+2.1%Added
Acuta Capital Partners, LLC52,918$1.64M1.27%+52,918New
Birchview Capital, LP40,601$1.26M0.73%+40,601New
Boothbay Fund Management, LLC21,291$660.2K0.01%+7,380+53.1%Added
Jane Street Group, LLC20,156$625.0K0.00%+7,514+59.4%Added
Seven Fleet Capital Management LP11,989$371.8K0.07%+11,989New
Geode Capital Management, LLC9,741$302.1K0.00%+9,741New
Vanguard Capital Management LLC9,216$285.8K0.00%−2,828−23.5%Reduced
Cormorant Asset Management, LP5,498$170.5K0.01%00.0%Unchanged
Vanguard Fiduciary Trust Co5,372$166.6K0.00%+1,758+48.6%Added
BlackRock, Inc.1,689$52.4K0.00%−13−0.8%Reduced
JPMorgan Chase & Co792$24.7K0.00%+790+39,500.0%Added
Morgan Stanley794$24.6K0.00%−3,290−80.6%Reduced
Wells Fargo & Company314$9.74K0.00%+304+3,040.0%Added
Group One Trading, L.P.234$7.26K0.00%+234New
Gen-Wealth Partners Inc166$5.15K0.00%+1+0.6%Added
Fortitude Family Office, LLC41$1.27K0.00%+1+2.5%Added
BFC Planning, Inc.15$4650.00%+1+7.1%Added
BNP Paribas Arbitrage, SA9$2790.00%+9New
Allworth Financial LP8$2490.00%00.0%Unchanged
Parallel Advisors, LLC6$1860.00%+3+100.0%Added
UBS Group AG4$1240.00%−4,726−99.9%Reduced
JDM Financial Group LLC2$620.00%+1+100.0%Added
Advisor Group Holdings, Inc.2$620.00%+2New
Westside Investment Management, Inc.1$310.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC1$310.00%00.0%Unchanged
FMR LLC1$310.00%+1New
Jones Financial Companies LLLP1$310.00%+1New
Balyasny Asset Management LLC69,970––+30.0%Added
Shay Capital LLC0$00.00%−17,468−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−567−100.0%Sold out
Operose Advisors LLC0$00.00%−159−100.0%Sold out
Barclays PLC0$00.00%−27−100.0%Sold out
Royal Bank of Canada––––Not filed